--- title: "21:00 ETViva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA" type: "News" locale: "en" url: "https://longbridge.com/en/news/279344307.md" description: "Viva Biotechis enhancing AI-driven drug discovery by optimizing the Proteina-Complexa model to design mini-binders targeting ActRIIA, a receptor linked to muscle wasting. Their collaboration with NVIDIA utilizes a 'Lab-in-the-Loop' workflow, integrating computational design with protein production and evaluation. This approach accelerates drug discovery, allowing for efficient and targeted designs at reduced costs and time. As a leading CRO in AI-driven drug discovery, Viva Biotech aims to further develop its AI algorithms and enhance its drug discovery processes." datetime: "2026-03-17T01:00:36.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/279344307.md) - [en](https://longbridge.com/en/news/279344307.md) - [zh-HK](https://longbridge.com/zh-HK/news/279344307.md) generator: "portal-rs" --- # 21:00 ETViva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA , /PRNewswire/ -- Monday, March 16th at 1:30 PM PT, **Viva Biotech (01873.HK)** optimizes the *Proteina-Complexa* model in advancing the design of mini-binders targeting ActRIIA, a receptor critical in muscle wasting and lean mass imbalance, aiming to accelerate the discovery of novel therapeutics with AI-driven designs with NVIDIA technology. The collaboration highlights Viva Biotech's "Lab-in-the-Loop" workflow, combining *de novo* computational design with high throughput protein production and biophysical evaluation to design ActRIIA binders. This integrated approach demonstrates how in silico predictions with real-world experimental validations can expedite drug discovery, showcasing the effectiveness of NVIDIA BioNeMo and Viva Biotech's AI-driven integrated drug discovery platform in optimizing drug candidates. As part of this effort, Viva Biotech leverages its AI technique for sequence selection and provide valuable feedback to improve the original *Proteina-Complexa* model. This iteration led to more efficient and targeted mini-binder designs. Guided by AI-driven insights, we successfully explored previously uncharted chemical space and significantly enhanced design specificity, achieving these advances at a fraction of the cost and time compared with conventional drug candidate nomination processes. For further details, please refer to the project paper: https://research.nvidia.com/labs/genair/proteina-complexa/. As a leading contract research organization (CRO) that specializes in AI-driven drug discovery (AIDD) and structure-based drug discovery (SBDD), Viva Biotech combines computational modeling, generative AI, and extensive wet lab capabilities to accelerate the discovery of small molecules, antibodies, peptides, fusion proteins, PROTACs, molecular glues, and RNA-targeting compounds. Looking ahead, Viva Biotech will further strengthen its AI algorithm development and leverage its AI platform in drug discovery and development. The company will continue to enhance its process to deliver high-quality, impactful solutions for its partners as a leading force in the AI-driven drug discovery era. Logo - https://mma.prnewswire.com/media/2934554/Viva\_Logo.jpg ### Related Stocks - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [ZIVO.US](https://longbridge.com/en/quote/ZIVO.US.md) - [562050.CN](https://longbridge.com/en/quote/562050.CN.md) - [VIR.US](https://longbridge.com/en/quote/VIR.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [159615.CN](https://longbridge.com/en/quote/159615.CN.md) - [516820.CN](https://longbridge.com/en/quote/516820.CN.md) - [520500.CN](https://longbridge.com/en/quote/520500.CN.md) - [01873.HK](https://longbridge.com/en/quote/01873.HK.md) - [NVDU.US](https://longbridge.com/en/quote/NVDU.US.md) - [07788.HK](https://longbridge.com/en/quote/07788.HK.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [159849.CN](https://longbridge.com/en/quote/159849.CN.md) - [512290.CN](https://longbridge.com/en/quote/512290.CN.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [NVDX.US](https://longbridge.com/en/quote/NVDX.US.md) - [NVDL.US](https://longbridge.com/en/quote/NVDL.US.md) - [516930.CN](https://longbridge.com/en/quote/516930.CN.md) - [159102.CN](https://longbridge.com/en/quote/159102.CN.md) - [588250.CN](https://longbridge.com/en/quote/588250.CN.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [588860.CN](https://longbridge.com/en/quote/588860.CN.md) - [560600.CN](https://longbridge.com/en/quote/560600.CN.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [159837.CN](https://longbridge.com/en/quote/159837.CN.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [NVDA.US](https://longbridge.com/en/quote/NVDA.US.md) ## Related News & Research - [Groq raises $350 million at a $3.5 billion valuation after Nvidia deal](https://longbridge.com/en/news/296132903.md) - [Bitdeer Ai Targets 350Mw Ai Cloud Data Center Capacity By Q1 2028](https://longbridge.com/en/news/296362972.md) - [NVIDIA Corporation Denies Report on Launching China-Customized AI Chip Before Year-End](https://longbridge.com/en/news/296549715.md) - [IREN Just Passed Its Biggest AI Test as Microsoft and Nvidia Bet Billions](https://longbridge.com/en/news/296533962.md) - [LG, NVIDIA deepen robotics collaboration under strategic MOU](https://longbridge.com/en/news/296287652.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**